Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) Sort ascending | Title |
---|---|---|---|
PAR-24-202 | August 31, 2024 | SI2/R00 | Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
PAR-23-166 | August 8, 2026 | S06 | Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) |
RFA-NS-23-003 | June 10, 2025 | RM1 | HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) |
RFA-NS-23-028 | June 10, 2025 | RM1 | HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) |
RFA-NS-25-012 | January 16, 2027 | R61/R33 | HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) |
NOT-NS-22-095 | June 25, 2025 | R61/R33 | HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery |
PAR-22-233 | March 2, 2025 | R61/R33 | Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) |
RFA-OD-22-010 | July 2, 2024 | R61/R33 | Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |
RFA-DC-24-001 | September 20, 2025 | R61 | BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) |
NOT-MH-24-115 | April 6, 2027 | R43/R44,R41/R42 | Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace |
RFA-NS-23-006 | April 5, 2025 | R43/R44 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) |
PAR-24-132 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) |
PAR-24-131 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) |
PAR-24-133 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) |
RFA-NS-23-007 | April 5, 2025 | R41/R42 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
PAR-24-134 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) |
RFA-NS-23-023 | October 3, 2024 | R34 | BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) |
PAR-23-285 | January 8, 2027 | R34 | Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) |
RFA-NS-22-027 | October 3, 2024 | R34 | BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) |
PAR-22-195 | September 8, 2025 | R25 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed) |